butorphanol has been researched along with Chemical Dependence in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (40.00) | 18.7374 |
1990's | 13 (43.33) | 18.2507 |
2000's | 5 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Howes, JF; Kotick, MP; Osgood, PF; Polazzi, JO; Razdan, RK; Schut, RN; Villarreal, JE | 1 |
Fisher, MA | 1 |
Fan, LW; Ho, IK; Ma, T; Park, Y; Rockhold, RW; Sasaki, K; Tanaka, S; Tien, LT | 1 |
Finch, MD; Haddox, JD; Kim, SS; Parente, ST; Rector, TS; Schloff, LA; Seifeldin, R | 1 |
Austin, RP | 1 |
Fujimura, H; Kadota, T; Kai, S; Kamikubo, K; Kawano, S; Koumura, H; Niwa, M; Nozaki, M; Takahashi, N | 1 |
Khazan, N; Steinfels, GF; Young, GA | 1 |
Vandam, LD | 1 |
Ho, IK; Hoskins, B; Jaw, SP; Makimura, M; Oh, KW | 2 |
Ho, IK; Hoskins, B; Jaw, SP; Makimura, M | 1 |
Drieze, J; Kamien, JB; Lukas, SE; Mello, NK; Mendelson, JH | 1 |
Ho, IK; Hoskins, B; Jaw, SP | 1 |
Barnes, AM; Ho, IK; Hoskins, B; Mamoon, AM | 1 |
Ho, IK; Hoshi, K; Ma, T; Oh, S | 1 |
Fisher, MA; Glass, S | 1 |
Feng, YZ; Ho, IK; Tokuyama, S; Wakabayashi, H; Zhu, H | 1 |
He, Z; Ho, IK; Ma, T; Tsang, BK; Wongchanapai, W | 1 |
Ameer, B; Salter, FJ | 1 |
Cohen, S; Wagner, JM | 1 |
Ho, IK; Horan, P | 1 |
Jasinski, DR; Preston, KL; Sullivan, JT; Testa, MP | 1 |
Bickel, WK; Bigelow, GE; Liebson, IA; Preston, KL | 1 |
Peachey, JE | 1 |
Gill, CJ; Pallasch, TJ | 1 |
Evens, RP; Pachter, IJ | 1 |
Bowen, JN; Clark, B; Evans, WS; Giordano, FL | 1 |
Brown, GR | 1 |
3 review(s) available for butorphanol and Chemical Dependence
Article | Year |
---|---|
Drug therapy reviews: evaluation of butorphanol tartrate.
Topics: Butorphanol; Clinical Trials as Topic; Drug Evaluation; Hemodynamics; Humans; Kinetics; Morphinans; Respiration; Substance-Related Disorders; Time Factors | 1979 |
Clinical observations of agonist-antagonist analgesic dependence.
Topics: Analgesics, Opioid; Butorphanol; Canada; Humans; Narcotic Antagonists; Pentazocine; Substance-Related Disorders | 1987 |
Butorphanol.
Topics: Anesthesia; Animals; Antitussive Agents; Butorphanol; Chemical Phenomena; Chemistry; Depression, Chemical; Diuretics; Dose-Response Relationship, Drug; Humans; Morphinans; Morphine; Naloxone; Nausea; Oxymorphone; Pain; Pulmonary Wedge Pressure; Rats; Respiration; Substance-Related Disorders | 1985 |
1 trial(s) available for butorphanol and Chemical Dependence
Article | Year |
---|---|
Drug therapy reviews: evaluation of butorphanol tartrate.
Topics: Butorphanol; Clinical Trials as Topic; Drug Evaluation; Hemodynamics; Humans; Kinetics; Morphinans; Respiration; Substance-Related Disorders; Time Factors | 1979 |
27 other study(ies) available for butorphanol and Chemical Dependence
Article | Year |
---|---|
Analgesic narcotic antagonists. 2. 8-Alkymorphinan-6-ones.
Topics: Acetates; Analgesics; Animals; Haplorhini; Humans; Mice; Morphinans; Morphine Dependence; Narcotic Antagonists; Rats; Reaction Time; Structure-Activity Relationship; Substance Withdrawal Syndrome; Substance-Related Disorders | 1980 |
Physicians and the pharmaceutical industry: a dysfunctional relationship.
Topics: Adverse Drug Reaction Reporting Systems; Analgesics, Opioid; Butorphanol; Drug Industry; Humans; Interprofessional Relations; Physicians; Social Control, Formal; Substance-Related Disorders; United States; United States Food and Drug Administration | 2003 |
Enhanced binding of nor-binaltorphimine to kappa-opioid receptors in rats dependent on butorphanol.
Topics: Animals; Brain; Butorphanol; Dose-Response Relationship, Drug; Male; Naltrexone; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders | 2003 |
Nurse addicted to stadol sues manufacturer. Case on point: Uhiren v. Bristol-Myers Squibb Company, Inc., 346 F.3d 824--AR (2003).
Topics: Analgesics, Opioid; Arkansas; Butorphanol; Drug Industry; Humans; Migraine Disorders; Nurse Practitioners; Professional Impairment; Substance-Related Disorders | 2003 |
Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data.
Topics: Adolescent; Adult; Analgesics, Opioid; Benzodiazepines; Butorphanol; Carisoprodol; Clinical Pharmacy Information Systems; Contraindications; Databases as Topic; Drug and Narcotic Control; Drug Prescriptions; Drug Utilization Review; Humans; Insurance Claim Review; Managed Care Programs; Middle Aged; Pain; Pattern Recognition, Automated; Prevalence; Substance-Related Disorders; United States | 2004 |
WHO Expert Committee on Drug Dependence.
Topics: 4-Butyrolactone; Advisory Committees; Azabicyclo Compounds; Buprenorphine; Butorphanol; Catha; Dronabinol; Drug and Narcotic Control; Drug Evaluation; Health Services Accessibility; Humans; Hydroxybutyrates; Ketamine; Piperazines; Psychotropic Drugs; Substance-Related Disorders; Thebaine; Tramadol; World Health Organization | 2006 |
Diversion of butorphanol.
Topics: Butorphanol; Drug and Narcotic Control; Humans; Morphinans; Substance-Related Disorders | 1983 |
[Physical dependence liabilities of butorphanol, a narcotic antagonist, and its main metabolites, norbutorphanol and hydroxybutorphanol].
Topics: Animals; Behavior, Animal; Butorphanol; Humans; Injections, Intravenous; Male; Morphinans; Morphine; Narcotics; Rats; Rats, Inbred Strains; Substance-Related Disorders | 1983 |
The new mixed agonist-antagonist analgesics, nalbuphine and butorphanol, vs. pentazocine: relapse and substitution in morphine-addict rats.
Topics: Analgesics; Animals; Butorphanol; Female; Humans; Morphinans; Morphine; Nalbuphine; Pentazocine; Rats; Self Administration; Sleep, REM; Substance-Related Disorders | 1981 |
Drug therapy: butorphanol.
Topics: Butorphanol; Hemodynamics; Humans; Morphinans; Neoplasms; Pain, Postoperative; Respiration; Substance-Related Disorders | 1980 |
Involvement of kappa-opioid receptors in opioid dependence/withdrawal: studies using butorphanol.
Topics: Animals; Butorphanol; Injections, Intraventricular; Male; Naloxone; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders | 1994 |
Effects of nor-binaltorphimine on butorphanol dependence.
Topics: Animals; Benzeneacetamides; Body Temperature; Body Weight; Butorphanol; Diarrhea; Down-Regulation; Drug Administration Schedule; Escape Reaction; Male; Naltrexone; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders; Tremor | 1993 |
The effects of nalbuphine and butorphanol treatment on cocaine and food self-administration by rhesus monkeys.
Topics: Analysis of Variance; Animals; Butorphanol; Cocaine; Conditioning, Operant; Feeding Behavior; Female; Macaca mulatta; Male; Nalbuphine; Receptors, Opioid; Self Administration; Substance-Related Disorders | 1993 |
Involvement of delta-opioid receptors in physical dependence on butorphanol.
Topics: Animals; Butorphanol; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Substance-Related Disorders | 1993 |
Comparative rewarding properties of morphine and butorphanol.
Topics: Animals; Butorphanol; Choice Behavior; Conditioning, Operant; Male; Morphine; Narcotics; Rats; Rats, Inbred Lew; Reward; Substance-Related Disorders | 1995 |
Increased release of excitatory amino acids in rat locus coeruleus in kappa-opioid agonist dependent rats precipitated by nor-binaltorphimine.
Topics: Animals; Benzeneacetamides; Butorphanol; Drug Evaluation, Preclinical; Excitatory Amino Acids; Locus Coeruleus; Male; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Substance-Related Disorders | 1997 |
Butorphanol (Stadol): a study in problems of current drug information and control.
Topics: Administration, Inhalation; Administration, Intranasal; Advertising; Analgesics, Opioid; Butorphanol; Drug and Narcotic Control; Humans; Injections, Intramuscular; Substance-Related Disorders; United States; United States Food and Drug Administration | 1997 |
The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Butorphanol; Glutamic Acid; Infusions, Parenteral; Locus Coeruleus; Male; Microdialysis; Morphine Dependence; Motor Activity; Naloxone; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Substance-Related Disorders | 1998 |
Supersensitivity of spinal opioid receptors to antagonists in intrathecal butorphanol and morphine dependence.
Topics: Animals; Butorphanol; Injections, Spinal; Male; Morphine Dependence; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance-Related Disorders | 1998 |
Effects of beta-funaltrexamine on butorphanol dependence.
Topics: Animals; Behavior, Animal; Body Temperature; Body Weight; Butorphanol; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred Strains; Reinforcement Schedule; Substance Withdrawal Syndrome; Substance-Related Disorders | 1992 |
Fibrous myopathy from butorphanol injections.
Topics: Adult; Butorphanol; Female; Fibrosis; Humans; Injections, Intramuscular; Muscles; Muscular Diseases; Pain; Palliative Care; Shoulder; Substance-Related Disorders | 1991 |
The physical dependence liability of butorphanol: a comparative study with morphine.
Topics: Animals; Behavior, Animal; Body Weight; Butorphanol; Injections, Intraventricular; Male; Morphine Dependence; Naloxone; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Substance-Related Disorders | 1991 |
Relative abuse liability and pharmacodynamics of transnasal and intramuscular butorphanol.
Topics: Administration, Intranasal; Butorphanol; Double-Blind Method; Humans; Injections, Intramuscular; Male; Substance-Related Disorders | 1990 |
Drug discrimination in human postaddicts: agonist-antagonist opioids.
Topics: Adult; Buprenorphine; Butorphanol; Conditioning, Operant; Discrimination, Psychological; Humans; Hydromorphone; Male; Nalbuphine; Pentazocine; Pupil; Substance-Related Disorders | 1989 |
Butorphanol and nalbuphine: a pharmacologic comparison.
Topics: Anesthesia, Dental; Butorphanol; Codeine; Drug Interactions; Heart; Humans; Kinetics; Morphinans; Nalbuphine; Preanesthetic Medication; Receptors, Opioid; Respiration; Substance-Related Disorders; Therapeutic Equivalency | 1985 |
A case of stadol dependence.
Topics: Butorphanol; Drug and Narcotic Control; Humans; Male; Morphinans; Personnel, Hospital; Substance-Related Disorders | 1985 |
Stadol dependence: another case.
Topics: Butorphanol; Humans; Male; Morphinans; Substance Withdrawal Syndrome; Substance-Related Disorders | 1985 |